Talimogene laherparepvec - Amgen
At a glance
- Drug Originator BioVex
- Drug Class Antineoplastics; Gene therapies; Granulocyte-macrophage colony-stimulating factors; Immunotherapies; Oncolytic viruses
- Mechanism of Action Cell death stimulants; Immunologic cytotoxicity; Immunostimulants
- USA Patent Applicants AMGEN INC
- USA Patents 9
- BLAs 1
- International Patents 68

Disclaimer